Related Experiment Video
Updated: Jun 16, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Fixed dilated pupils and tacrolimus toxicity in paediatric liver transplant patients
Claire Westrope1, Helen Rowlands, Kevin Morris
1Paediatric Intensive Care Unit, Birmingham Children's Hospital NHS Foundation Trust, Birmingham, UK. claire@westropes.co.uk
Insights
High tacrolimus levels in children after liver transplants can cause fixed dilated pupils. This post-operative complication is linked to drug concentrations exceeding 30 ng/mL.
Area of Science:
- Pediatric Surgery
- Pharmacology
- Ophthalmology
Background:
- Tacrolimus is an immunosuppressant crucial for preventing organ rejection in pediatric transplant recipients.
- Monitoring tacrolimus levels is essential to balance efficacy and toxicity, especially in pediatric patients.
Observation:
- A case series identified four pediatric patients presenting with fixed dilated pupils post-liver or liver-small bowel transplantation.
- This neurological sign correlated with elevated serum tacrolimus concentrations, surpassing 30 nanograms/millilitre.
Findings:
- Fixed dilated pupils represent a potential, albeit rare, clinical manifestation of tacrolimus toxicity in pediatric transplant patients.
- The observed association highlights the importance of vigilant neurological monitoring in the immediate post-operative phase.
Implications:
- Early recognition of fixed dilated pupils may prompt timely tacrolimus level assessment and dose adjustment.
- This finding contributes to a better understanding of the neuro-ophthalmic side effects of tacrolimus in pediatric transplantation.
Abstract:
We report a case series of four children who developed fixed dilated pupils associated with high tacrolimus levels (>30 nanograms/millilitre [ng/mL]) in the immediate post-operative period following isolated liver or liver and small bowel transplantation.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacokinetics in Pediatric Patients: Drug Excretion
